Aura Biosciences, Inc.
AURA
$6.55
$0.081.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 23.09M | 23.24M | 22.81M | 21.84M | 20.71M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 108.69M | 102.84M | 96.11M | 93.09M | 90.35M |
| Operating Income | -108.69M | -102.84M | -96.11M | -93.09M | -90.35M |
| Income Before Tax | -101.25M | -94.61M | -86.81M | -82.99M | -80.50M |
| Income Tax Expenses | 133.00K | 85.00K | 113.00K | 226.00K | 183.00K |
| Earnings from Continuing Operations | -101.38 | -94.70 | -86.92 | -83.22 | -80.69 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -101.38M | -94.70M | -86.92M | -83.22M | -80.69M |
| EBIT | -108.69M | -102.84M | -96.11M | -93.09M | -90.35M |
| EBITDA | -107.51M | -101.63M | -94.89M | -91.83M | -89.06M |
| EPS Basic | -1.96 | -1.90 | -1.75 | -1.73 | -1.79 |
| Normalized Basic EPS | -1.22 | -1.19 | -1.09 | -1.08 | -1.12 |
| EPS Diluted | -1.96 | -1.90 | -1.75 | -1.73 | -1.79 |
| Normalized Diluted EPS | -1.22 | -1.19 | -1.09 | -1.08 | -1.12 |
| Average Basic Shares Outstanding | 207.74M | 199.27M | 198.60M | 193.31M | 181.84M |
| Average Diluted Shares Outstanding | 207.74M | 199.27M | 198.60M | 193.31M | 181.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |